UPDATE: Danaher Q1 Revenues Rise 5 Percent; CEO Culp Retiring Next Year | GenomeWeb

The story has been updated to include comments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Wednesday that total revenues for the first quarter increased 5 percent year over year as revenues from its Life Sciences and Diagnostics segment rose nearly 6 percent.

The company also announced that its President and CEO Lawrence Culp will retire on March 1, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.